NeuroBo Pharmaceuticals Enters Into Term Sheet With MThera P

/PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company on a quest to transform cardiometabolic diseases, today...

Related Keywords

United States , South Korea , Seoul , Soult Ukpyolsi , Boston , Massachusetts , Michael Miller , Mthera Pharma , Joseph Hooker , Drug Administration , Neurobo Pharmaceuticals Inc , Neurobo Pharmaceuticals , Prnewswire Neurobo Pharmaceuticals Inc , Rx Communications Group , Nasdaq , Mthera Pharma Co Ltd , Exchange Commission On , Securities Exchange , Interim President , Chief Executive Officer , Non Alcoholic Steatohepatitis , G Protein Coupled Receptor , Private Securities Litigation Reform Act , Securities Exchange Act , Annual Report , Exchange Commission ,